IP Library › Granted Patent US 12,667,414
Granted Patent B2
US 12,667,414 · App. 17/858,223 · Granted Jun 30, 2026

Endoscopic treatment device and endoscopic treatment method

Inventors: Nobuko Matsuo (Hachioji, JP); Keiichi Sato (Hachioji, JP); Takuya Okumura (Hamburg, DE); Yuta Hayashi (Kawasaki, JP)
Assignee: OLYMPUS CORPORATION
A61B18/1492A61B1/0008A61B1/005A61B1/015A61B1/2736A61B2018/00494A61B2018/00595
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,667,414
App. No.
17/858,223
Filed
Jul 6, 2022
Granted
Jun 30, 2026
Kind
B2
Art Unit
3771
USPC
606/108
Abstract

A treatment device and an endoscopic treatment method are disclosed. The treatment device includes a first pipeline that is made of material having electrical insulation, and includes an internal space; an electrode that is energizable with high frequency current; a distal-end tip that is attached to a distal end of the first pipeline, and includes a distal-end opening in communication with the internal space of the first pipeline; and a second pipeline that is inserted through the first pipeline and through which liquid can pass. The endoscopic treatment method includes puncturing a treatment target and performing a local injection using the treatment device.

Claims (27)

1 . A treatment device, comprising:

a pipeline configured to deliver liquid therethrough;

a wire that is inserted through the pipeline, the wire being advanceable and retractable with respect to the pipeline, the wire being a first conductor;

a handle main body located at a proximal end of the pipeline;

a slider attached to the handle main body; and

a second conductor fixed with respect to the handle main body, wherein

a proximal-end portion of the wire and the second conductor are configured to electrically switch between a contact state and a non-contact state in response to movement of the slider with respect to the handle main body.

2 . The treatment device according to claim 1 , further comprising a distal-end tip attached to a distal end of the pipeline, the distal-end tip including a distal-end opening that is in communication with an internal space of the pipeline.

3 . The treatment device according to claim 2 , wherein the distal-end tip includes side openings that are formed in a lateral side of the distal-end tip, and are in communication with the internal space of the pipeline.

4 . The treatment device according to claim 3 , wherein the side openings are slits that are also in communication with the distal-end opening.

5 . The treatment device according to claim 1 , wherein the distal end of the wire is configured to puncture tissue.

6 . The treatment device according to claim 1 , wherein the pipeline is configured to be moved along an axial direction of the pipeline with respect to the wire between: (i) a first position in which a distal end of the pipeline is located distally relative to a distal end of the wire in the axial direction, and (ii) a second position at which the distal end of the pipeline is located proximally relative to the distal end of the wire in the axial direction.

7 . The treatment device according to claim 1 , wherein the slider is connected to the wire in the handle main body.

8 . A treatment device, comprising:

a gas pipeline;

a liquid pipeline;

a wire that is inserted through the liquid pipeline, the wire being advanceable and retractable with respect to the liquid pipeline;

a handle main body that is attached to a proximal end of the gas pipeline;

a slider attached to the handle main body, the slider being connected to the wire in the handle main body; and

a conductor that is fixed with respect to the handle main body, wherein

a proximal-end portion of the wire and the conductor are configured to electrically switch between a contact state and a non-contact state in response to a movement of the slider with respect to the handle main body.

9 . The treatment device according to claim 8 , further comprising a distal-end tip attached to a distal end of the gas pipeline, the distal-end tip including a distal-end opening that is in communication with an internal space of the gas pipeline.

10 . The treatment device according to claim 9 , wherein the distal-end tip includes side openings that are formed in a lateral side of the distal-end tip, and are in communication with the internal space of the gas pipeline.

11 . The treatment device according to claim 10 , wherein the side openings are slits that are in communication with the distal-end opening.

12 . The treatment device according to claim 8 , wherein the distal end of the wire is configured to puncture tissue.

13 . The treatment device according to claim 8 , wherein the liquid pipeline is configured to be moved along an axial direction of the gas pipeline with respect to the gas pipeline between: (i) a first position in which a distal end of the liquid pipeline is located distally relative to a distal-end opening of the gas pipeline in the axial direction of the gas pipeline, and (ii) a second position at which the distal end of the liquid pipeline is located proximally relative to the distal-end opening in the axial direction.

14 . The treatment device according to claim 8 , wherein the wire is a conductor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2023
From: MATSUO, NOBUKO; SATO, KEIICHI; OKUMURA, TAKUYA; HAYASHI, YUTA
To: OLYMPUS CORPORATION
Reel/Frame 062331/0940 →
Continuity (2)
Continuation PCTJP2020000451 · Jan 9, 2020
Related Publication 20220338716A1 · Oct 27, 2022
References Cited (59)
US 4562838A · Walker · 1986 [cited by examiner]
US 5318565A · Kuriloff · 1994 [cited by examiner]
US 5413575A · Haenggi · 1995 [cited by examiner]
US 5626577A · Harris · 1997 [cited by examiner]
US 5891140A · Ginn · 1999 [cited by examiner]
US 6197026B1 · Farin et al. · 2001 [cited by applicant]
US 6293945B1 · Parins · 2001 [cited by examiner]
US 7623899B2 · Worley et al. · 2009 [cited by applicant]
US 8425509B2 · Longo · 2013 [cited by examiner]
US 9119622B2 · Rahmani · 2015 [cited by applicant]
US 9289261B2 · Shvetsov · 2016 [cited by examiner]
US 9592070B2 · Inoue · 2017 [cited by applicant]
US 9795505B2 · Yu · 2017 [cited by examiner]
US 10675084B2 · Lowry · 2020 [cited by examiner]
US 12114910B2 · Kim · 2024 [cited by examiner]
US 20070066985A1 · Geitz et al. · 2007 [cited by applicant]
US 20070135803A1 · Belson · 2007 [cited by examiner]
US 20070213704A1 · Truckai et al. · 2007 [cited by applicant]
US 20130090643A1 · Williams · 2013 [cited by examiner]
US 20130090644A1 · Williams · 2013 [cited by examiner]
US 20140005660A1 · Edwards et al. · 2014 [cited by applicant]
US 20140148732A1 · Radl · 2014 [cited by examiner]
US 20150005760A1 · Poulsen · 2015 [cited by examiner]
US 20150238219A1 · Karwei · 2015 [cited by applicant]
US 20160192979A1 · Mikkaichi · 2016 [cited by examiner]
US 20170042522A1 · Kogiso · 2017 [cited by examiner]
US 20170071653A1 · Enderle et al. · 2017 [cited by applicant]
US 20170312029A1 · Schaer · 2017 [cited by applicant]
US 20190069944A1 · Fischer · 2019 [cited by applicant]
US 20190090975A1 · Hernandez · 2019 [cited by examiner]
US 20190201047A1 · Yates · 2019 [cited by examiner]
US 20190269429A1 · Clark, III · 2019 [cited by examiner]
US 20190307506A1 · Gelbart · 2019 [cited by examiner]
DE 102010061059A1 · 2012 [cited by applicant]
JP H01015362Y2 · 1989 [cited by applicant]
JP H08336542A · 1996 [cited by applicant]
JP 2001178740A · 2001 [cited by examiner]
JP 2002503508A · 2002 [cited by applicant]
JP 2002301088A · 2002 [cited by examiner]
JP 2003534037A · 2003 [cited by applicant]
JP 2007313345A · 2007 [cited by applicant]
JP 2008543355A · 2008 [cited by applicant]
JP 2015062733A · 2015 [cited by applicant]
JP 2017051615A · 2017 [cited by applicant]
JP 2017153698A · 2017 [cited by examiner]
WO 2006119892A1 · 2006 [cited by applicant]
Jun. 6, 2023 Office Action issued in Japanese Patent Application No. 2021-570008. [cited by applicant]
Dec. 6, 2023 Notice of Allowance issued in U.S. Appl. No. 17/071,050. [cited by applicant]
Mar. 6, 2025 Office Action issued in U.S. Appl. No. 17/859,491. [cited by applicant]
Tanabe et al., “A Novel Endoscopic Fundoplication for Gastroesophageal Reflux Disease; Anti-Reflux Mucosal Ablation (ARMA),” Gastrointestinal Endoscopy, 2019, vol. 89, No. 6S, p. AB190. [cited by applicant]
Sumi et al.,“Esophageal hiatal hernia and GERD: New developments in endoscopic diagnosis and treatment,” Endoscopia Digestiva, May 2020, vol. 32, No. 5, pp. 707-713. [cited by applicant]
Mar. 24, 2020 International Search Report issued in International Patent Application No. PCT/JP2020/000451. [cited by applicant]
Feb. 9, 2021 International Search Report issued in International Patent Application No. PCT/JP2020/048466. [cited by applicant]
Jan. 10, 2020 Office Action issued in U.S. Appl. No. 16/279,381. [cited by applicant]
Jul. 17, 2020 Notice of Allowance issued in U.S. Appl. No. 16/279,381. [cited by applicant]
Apr. 18, 2023 Office Action issued in Japanese Patent Application No. 2021-569661. [cited by applicant]
Jun. 6, 2025 Office Action issued in Chinese Patent Application No. 202080092098.1. [cited by applicant]
Jul. 8, 2025 Office Action issued in U.S. Appl. No. 17/859,491. [cited by applicant]
Mar. 12, 2026 Office Action issued in Chinese Patent Application No. 202080092098.1. [cited by applicant]